CN106109760A - For treating the medicine of prolapse of lumbar intervertebral disc - Google Patents
For treating the medicine of prolapse of lumbar intervertebral disc Download PDFInfo
- Publication number
- CN106109760A CN106109760A CN201610673578.2A CN201610673578A CN106109760A CN 106109760 A CN106109760 A CN 106109760A CN 201610673578 A CN201610673578 A CN 201610673578A CN 106109760 A CN106109760 A CN 106109760A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- radix
- intervertebral disc
- lumbar intervertebral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 208000012287 Prolapse Diseases 0.000 title claims abstract description 22
- 229940079593 drug Drugs 0.000 claims abstract description 17
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 241000628997 Flos Species 0.000 claims abstract description 9
- 241000283956 Manis Species 0.000 claims abstract description 9
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 9
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 9
- 241000237636 Pheretima Species 0.000 claims abstract description 9
- 241000522620 Scorpio Species 0.000 claims abstract description 9
- 239000009490 scorpio Substances 0.000 claims abstract description 9
- 210000000582 semen Anatomy 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000000706 filtrate Substances 0.000 claims description 15
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 6
- 229940069338 potassium sorbate Drugs 0.000 claims description 6
- 235000010241 potassium sorbate Nutrition 0.000 claims description 6
- 239000004302 potassium sorbate Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 230000006837 decompression Effects 0.000 claims description 5
- 238000007598 dipping method Methods 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 208000002193 Pain Diseases 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 230000008961 swelling Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 230000001684 chronic effect Effects 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 208000006820 Arthralgia Diseases 0.000 description 8
- 210000001015 abdomen Anatomy 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000008035 Back Pain Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 206010023201 Joint contracture Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/746—Morinda
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Insects & Arthropods (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of medicine for treating prolapse of lumbar intervertebral disc, be made up of the raw material of following weight parts proportioning: eupolyphoge sinensis 5 15 parts, Scorpio 5 15 parts, Zaocys 5 15 parts, 12 24 parts of Flos Carthami, Radix Angelicae Pubescentis 8 15 parts, Radix Saposhnikoviae 5 15 parts, Rhizoma Curculiginis 12 18 parts, the Cortex Eucommiae 8 15 parts, Radix Morindae Officinalis 15 20 parts, Squama Manis 5 15 parts, Pheretima 18 25 parts, Radix Aconiti Kusnezoffii 8 15 parts, Semen Strychni 8 18 parts, Radix Notoginseng 15 25 parts.The present invention treats the medicine that chronic lumbar vertebrae intercalated disc is prominent, choose 14 kinds of natural Chinese medicine scientific compatibility, formula is simple, and each crude drug synergism plays blood circulation promoting and blood stasis dispelling, the effect of reducing swelling and alleviating pain, instant effect, treating both the principal and secondary aspects of a disease, has no side effect, and its preparation method is simple, taking convenience, low cost, effective percentage reaches more than 96%.
Description
Technical field
The present invention relates to Chinese medicine, a kind of medicine for treating prolapse of lumbar intervertebral disc.
Background technology
Prolapse of lumbar intervertebral disc is one of the most common illness of Orthopaedics Clinic, is also the most common reason of lumbago and skelalgia.
Review history, just describe the outward appearance of intervertebral disc as far back as Vesalius in 1543.The twenties in 20th century, the Shmorl of Germany is successively
Deliver 11 relevant intervertebral disc to dissect and the article of pathology, intervertebral disc has been done wide research.1932, Barr was first
Proposition prolapse of lumbar intervertebral disc is the reason that lumbago and skelalgia is possible.Thereafter, Barr and Mixter propose first relevant lumbar intervertebral disc dash forward
Go out concept and the Therapeutic Method of disease.Hereafter, lumbar intervertebral disc prominent (taking off) is gone out the basic research of disease the most deeply, thus more
Improve the clinical diagnosis of primary disease and the effect for the treatment of.
Prolapse of lumbar intervertebral disc, is primarily due to lumbar intervertebral disc each several part (vertebral pulp, fibrous ring and cartilaginous lamina), especially marrow
Core, after having degenerative change in various degree, under the effect of external force factor, the Anular disruption of intervertebral disc, nucleus pulposus from
Rupture part prominent (or abjection), in rear or intraspinal tube, to cause adjacent ridge nerve root stimulated or oppress, thus produce waist
Portion's pain, a series of clinical symptoms such as side lower limb or double numbness of lower limbs, pain.According to prominent position can be divided into central type,
The other type of central authorities, lateral and far lateral.Some types projecting degree is heavier, and chronic phase sharp ache.
The method of clinical treatment chronic lumbar vertebrae disc herniation is more, but curative effect is the most not ideal enough, and treatment cycle is long, and treats
Imitate the most notable.
Summary of the invention
It is an object of the invention to provide a kind of good effect, low cost, have no side effect for treating prolapse of lumbar intervertebral disc
Medicine.
The technical scheme realizing the object of the invention is:
A kind of medicine for treating prolapse of lumbar intervertebral disc, is made up of the raw material of following weight parts proportioning:
Eupolyphoge sinensis 5-15 part, Scorpio 5-15 part, Zaocys 5-15 part, Flos Carthami 12-24 part, Radix Angelicae Pubescentis 8-15 part, Radix Saposhnikoviae 5-15 part,
Rhizoma Curculiginis 12-18 part, Cortex Eucommiae 8-15 part, Radix Morindae Officinalis 15-20 part, Squama Manis 5-15 part, Pheretima 18-25 part, Radix Aconiti Kusnezoffii 8-15 part, Semen Strychni
Sub-8-18 part, Radix Notoginseng 15-25 part.
The above-mentioned medicine for treating prolapse of lumbar intervertebral disc, optimum weight part proportioning of each raw material is:
Eupolyphoge sinensis 10 parts, Scorpio 10 parts, Zaocys 10 parts, 18 parts of Flos Carthami, Radix Angelicae Pubescentis 12 parts, Radix Saposhnikoviae 10 parts, Rhizoma Curculiginis 15 parts, the Cortex Eucommiae
12 parts, Radix Morindae Officinalis 18 parts, Squama Manis 10 parts, Pheretima 22 parts, Radix Aconiti Kusnezoffii 12 parts, Semen Strychni 13 parts, Radix Notoginseng 20 parts.
Described raw medicinal material is in shop of Chinese medicines and commercially available.
The preparation method of medicine of the present invention is as follows:
(1) weigh each crude drug by weight ratio, whole crude drug are ground into coarse powder, are mixed together and are placed in container
In, after adding alcohol dipping 6-8 days that 5-7 times of concentration of material quantity is 40-60%, filter and remove residue, decompression filtrate recycling ethanol is extremely
Taste without alcohol, obtains concentrated solution 80-100 part, standby；
(2) in the concentrated solution that step (1) prepares, add 800-1000 part water and 0.8-1 part potassium sorbate, stir evenly, stand
24-30h, filters, obtains filtrate, standby；
(3) separately with 60-100 part sucrose, add 120-140 part water boil 30-40min, filter, standby；
(4) the filtrate mixing of step (2) and (3) is placed in container, adds 800-1000 part water, bottle after cooling, seal
After carry out sterilization treatment, make product.
In the present invention, the pharmacology of each crude drug, effect are as follows:
Eupolyphoge sinensis: removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones.For injured bone, blood stasis amenorrhea, lump in the abdomen mass in the abdomen.
Scorpio: endogenous wind stopping spasmolytic, removing obstruction in the collateral to relieve pain, dispersing pathogen accumulation.For liver-wind stirring up internally, spasm is twitched, infantile convulsion, middle air portHemiplegia, tetanus, rheumatoid arthritis stubborn, migraine and general headache, skin infection, scrofula.
Zaocys: dispel the wind, dredging collateral, effect of relieving convulsion.For treating rheumatoid arthritis stubborn, numbness contracture, middle air port eye fish sticking its mouth out of the water tiltedly,
Hemiplegia, tic spasm, tetanus, leprosy, scabies.
Flos Carthami: there is promoting blood circulation to restore menstrual flow, effect of eliminating stasis to stop pain.For amenorrhea, dysmenorrhea, lochia, lump in the abdomen mass in the abdomen, the thoracic obstruction
Pained, the stagnant stomachache of the stasis of blood, breast side of body twinge, injury from falling down, skin infection swells and ache.
Radix Angelicae Pubescentis: expelling wind and dampness；Dispersing cold for relieving pain.For anemofrigid-damp arthralgia；Lumbocrural pain；Few the moon volt wind headache, toothache of having a headache.
Radix Saposhnikoviae: have expelling pathogenic wind from the body surface, removing dampness to relieve pain, effect of relieving convulsion.
Rhizoma Curculiginis: there is reinforcing the kidney and supporting YANG, benefiting essence-blood, bone and muscle strengthening and the effect of promoting the circulation of blood detumescence, be mainly used in insufficiency of kidney-YANG, sexual impotence
The diseases such as seminal emission, chronic consumptive disease internal injury and bones and muscles pain.
The Cortex Eucommiae: be the dry bark of the Eucommiaceae plant Cortex Eucommiae, is Chinese famous and precious tonic herb.Its sweet in the mouth, warm in nature.There is benefit
Liver and kidney tonifying, bone and muscle strengthening, Chong and Ren Meridians regulating, solid through antiabortive effect.The lumbago and skelalgia or aching and limp unable that insufficiency of kidney-YANG causes, liver can be treated
The diseases such as born of the same parents' tire that the deficiency of vital energy causes is not solid, scrotum pruritus due to damp pathogen.
Squama Manis: can blood circulation promoting and dispersing pathogen accumulation, stimulating milk secretion of stimulating the menstrual flow, the routed heavily fortified point of eliminating carbuncle.Main blood stasis amenorrhea, lump in the abdomen, rheumatic arthralgia, agalactia,
Carbuncle, scrofula etc..
Pheretima: have heat clearing away arresting convulsion, dredging collateral, relieving asthma, effect of diuresis.After parch for high heat, coma, infantile convulsion tic,
The diseases such as arthralgia, dyspnea and cough due to lung-heat, oliguria edema, hypertension.
Radix Aconiti Kusnezoffii: expelling wind and removing dampness, antalgic.For anemofrigid-damp arthralgia, arthralgia, trusted subordinate's cold type of pain, colic of cold type is had a pain, and anaesthetizes
Pain relieving.
Semen Strychni: 1. removing obstruction in the collateral to relieve pain: numb with dispelling the wind and dampness pathogens insensitive impediment or contracture.2, dispersing swelling and dissipating binds: with controlling wound pain caused by ecchymoma
And ulcer sore pain.In recent years plant cancerous protuberance with Zhiduo County, have certain curative effect.3. treatment poliomyelitis sequela, prolapse of lumbar intervertebral disc, three
Fork neuralgia, rheumatoid arthritis, traumatic injury, pain due to blood stasis, anemofrigid-damp arthralgia, general joint contracture, numbness, cancerous protuberance etc..
Cure mainly throat arthralgia pain, swollen ulcer drug, migratory arthralgia pain, fracture, facial paralysis, myasthenia gravis.
Radix Notoginseng: dissipating blood stasis stops blooding, subduing swelling and relieving pain.For spitting blood, spit blood, epistaxis, to have blood in stool, metrorrhagia, traumatic hemorrhage, chest and abdomen sting
Bitterly, tumbling and swelling.
The present invention, for treating the medicine of prolapse of lumbar intervertebral disc, chooses 14 kinds of natural Chinese medicine scientific compatibility, and formula is simple, respectively
Crude drug synergism plays blood circulation promoting and blood stasis dispelling, the effect of reducing swelling and alleviating pain, instant effect, and treating both the principal and secondary aspects of a disease has no side effect, and its system
Preparation Method is simple, taking convenience, low cost.
Detailed description of the invention
Below in conjunction with embodiment, present invention is further described, but is not limitation of the invention.
Embodiment 1
A kind of medicine for treating prolapse of lumbar intervertebral disc, is made up of the raw material of following weight parts proportioning:
Eupolyphoge sinensis 5kg, Scorpio 5kg, Zaocys 5kg, Flos Carthami 12kg, Radix Angelicae Pubescentis 8kg, Radix Saposhnikoviae 5kg, Rhizoma Curculiginis 12kg, Cortex Eucommiae 8kg,
Radix Morindae Officinalis 15kg, Squama Manis 5kg, Pheretima 18kg, Radix Aconiti Kusnezoffii 8kg, Semen Strychni 8kg, Radix Notoginseng 15kg.
The preparation method of medicine of the present invention is as follows:
(1) weigh each crude drug by weight ratio, whole crude drug are ground into coarse powder, are mixed together and are placed in container
In, adding 5 times of concentration of material quantity is the alcohol dipping of 40% after 6 days, filter and remove residue, decompression filtrate recycling ethanol to without alcohol taste,
Obtain concentrated solution 80kg, standby；
(2) in the concentrated solution that step (1) prepares, add 800kg water and 0.8kg potassium sorbate, stir evenly, stand 24h, mistake
Filter, obtains filtrate, standby；
(3) separately use 60kg sucrose, add 120kg water boil 30min, filter, standby；
(4) filtrate of step (2) and (3) mixed be placed in container, add 800kg water, bottle after cooling, seal after carry out
Sterilization treatment, makes product.
Embodiment 2
A kind of medicine for treating prolapse of lumbar intervertebral disc, is made up of the raw material of following weight parts proportioning:
Eupolyphoge sinensis 10kg, Scorpio 10kg, Zaocys 10kg, Flos Carthami 18kg, Radix Angelicae Pubescentis 12kg, Radix Saposhnikoviae 10kg, Rhizoma Curculiginis 15kg, the Cortex Eucommiae
12kg, Radix Morindae Officinalis 18kg, Squama Manis 10kg, Pheretima 22kg, Radix Aconiti Kusnezoffii 12kg, Semen Strychni 13kg, Radix Notoginseng 20kg.
The preparation method of medicine of the present invention is as follows:
(1) weigh each crude drug by weight ratio, whole crude drug are ground into coarse powder, are mixed together and are placed in container
In, adding 6 times of concentration of material quantity is the alcohol dipping of 50% after 7 days, filter and remove residue, decompression filtrate recycling ethanol to without alcohol taste,
Obtain concentrated solution 90kg, standby；
(2) in the concentrated solution that step (1) prepares, add 900kg water and 0.9kg potassium sorbate, stir evenly, stand 27h, mistake
Filter, obtains filtrate, standby；
(3) separately use 80kg sucrose, add 130kg water boil 35min, filter, standby；
(4) filtrate of step (2) and (3) mixed be placed in container, add 900kg water, bottle after cooling, seal after carry out
Sterilization treatment, makes product.
Embodiment 3
A kind of medicine for treating prolapse of lumbar intervertebral disc, is made up of the raw material of following weight parts proportioning:
Eupolyphoge sinensis 15kg, Scorpio 15kg, Zaocys 15kg, Flos Carthami 24kg, Radix Angelicae Pubescentis 15kg, Radix Saposhnikoviae 15kg, Rhizoma Curculiginis 18kg, the Cortex Eucommiae
15kg, Radix Morindae Officinalis 20kg, Squama Manis 15kg, Pheretima 25kg, Radix Aconiti Kusnezoffii 15kg, Semen Strychni 18kg, Radix Notoginseng 25kg.
The preparation method of medicine of the present invention is as follows:
(1) weigh each crude drug by weight ratio, whole crude drug are ground into coarse powder, are mixed together and are placed in container
In, adding 7 times of concentration of material quantity is the alcohol dipping of 60% after 8 days, filter and remove residue, decompression filtrate recycling ethanol to without alcohol taste,
Obtain concentrated solution 100kg, standby；
(2) in the concentrated solution that step (1) prepares, add 1000kg water and 1kg potassium sorbate, stir evenly, stand 30h, mistake
Filter, obtains filtrate, standby；
(3) separately use 100kg sucrose, add 140kg water boil 40min, filter, standby；
(4) filtrate of step (2) and (3) mixed be placed in container, add 1000kg water, bottle after cooling, seal laggard
Row sterilization treatment, makes product.
In order to prove the clinical efficacy of Chinese medicine of the present invention further, select to accept 90 examples in patient for medical treatment, to medicine of the present invention
Curative effect carry out clinical observation.In age 30-50 year, being randomly divided into 3 groups, often group is 30 examples, respectively experimental group 1-3 group.
Experimental group 1-3 group takes the medicine of embodiment 1-3 respectively, three times a day, takes 3g with yellow wine every time, within 20 days, is one
The individual course for the treatment of, take 1-2 the course for the treatment of continuously.The most effective 84 examples, effective 86 examples, cure 83 examples, invalid 4 examples, cure rate 92%, have
Efficiency 96%.
Claims (7)
1., for treating a medicine for prolapse of lumbar intervertebral disc, it is characterized in that: be made up of the raw material of following weight parts proportioning:
Eupolyphoge sinensis 5-15 part, Scorpio 5-15 part, Zaocys 5-15 part, Flos Carthami 12-24 part, Radix Angelicae Pubescentis 8-15 part, Radix Saposhnikoviae 5-15 part, Rhizoma Curculiginis
12-18 part, Cortex Eucommiae 8-15 part, Radix Morindae Officinalis 15-20 part, Squama Manis 5-15 part, Pheretima 18-25 part, Radix Aconiti Kusnezoffii 8-15 part, Semen Strychni 8-
18 parts, Radix Notoginseng 15-25 part.
Medicine for treating prolapse of lumbar intervertebral disc the most according to claim 1, is characterized in that: the weight portion of each raw material is joined
Than being:
Eupolyphoge sinensis 10 parts, Scorpio 10 parts, Zaocys 10 parts, 18 parts of Flos Carthami, Radix Angelicae Pubescentis 12 parts, Radix Saposhnikoviae 10 parts, Rhizoma Curculiginis 15 parts, the Cortex Eucommiae 12
Part, Radix Morindae Officinalis 18 parts, Squama Manis 10 parts, Pheretima 22 parts, Radix Aconiti Kusnezoffii 12 parts, Semen Strychni 13 parts, Radix Notoginseng 20 parts.
3., for treating a preparation method for the medicine of prolapse of lumbar intervertebral disc, it is characterized in that: specifically comprise the following steps that
(1) weigh each crude drug by weight ratio, whole crude drug are ground into coarse powder, be mixed together and be placed in container, add
After entering alcohol dipping 6-8 days of 5-7 times of concentration of material quantity, filter and remove residue, decompression filtrate recycling ethanol, to without alcohol taste, obtains concentrated solution
80-100 part is standby；
(2) in the concentrated solution that step (1) prepares, add water and potassium sorbate, stir evenly, stand 24-30h, filter, obtain filtrate, standby
With；
(3) separately with sucrose, add water boil 30-40min, filter, standby；
(4) filtrate of step (2) and (3) mixed be placed in container, add water, bottle after cooling, seal after carry out sterilization treatment,
Make product.
The preparation method of the medicine for treating prolapse of lumbar intervertebral disc the most according to claim 3, is characterized in that: described step
The concentration of the ethanol suddenly added in (1) is 40-60%.
The preparation method of the medicine for treating prolapse of lumbar intervertebral disc the most according to claim 3, is characterized in that: described step
Suddenly in (2), the addition of water is 800-1000 part, and the addition of potassium sorbate is 0.8-1 part.
The preparation method of the medicine for treating prolapse of lumbar intervertebral disc the most according to claim 3, is characterized in that: described step
Suddenly the amount of the sucrose in (3) is 60-100 part, and the amount of water is 120-140 part.
The preparation method of the medicine for treating prolapse of lumbar intervertebral disc the most according to claim 3, is characterized in that: described step
Suddenly in (4), the addition of water is 800-1000 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610673578.2A CN106109760A (en) | 2016-08-16 | 2016-08-16 | For treating the medicine of prolapse of lumbar intervertebral disc |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610673578.2A CN106109760A (en) | 2016-08-16 | 2016-08-16 | For treating the medicine of prolapse of lumbar intervertebral disc |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106109760A true CN106109760A (en) | 2016-11-16 |
Family
ID=57258185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610673578.2A Pending CN106109760A (en) | 2016-08-16 | 2016-08-16 | For treating the medicine of prolapse of lumbar intervertebral disc |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106109760A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105012592A (en) * | 2015-07-27 | 2015-11-04 | 刘杰 | Drug for treatment of chronic lumbar disc herniation |
-
2016
- 2016-08-16 CN CN201610673578.2A patent/CN106109760A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105012592A (en) * | 2015-07-27 | 2015-11-04 | 刘杰 | Drug for treatment of chronic lumbar disc herniation |
Non-Patent Citations (1)
| Title |
|---|
| 余宜春: "综合保守治疗腰椎间盘突出症250例", 《中医药临床杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102626505A (en) | Massaging paste based on Chinese medicinal herbs and preparation method thereof | |
| CN104027462A (en) | Traditional Chinese medicine preparation for treating osteoarthritis and preparing method thereof | |
| CN102349989A (en) | Traditional Chinese medicine for treating cervical spondylosis | |
| CN104922363A (en) | Traditional Chinese medicine composite for treating osteoproliferation | |
| CN104026670A (en) | Manyprickle acathopanax root soup with function of strengthening tendons and bones and production method thereof | |
| CN106138468A (en) | For treating the medicine of cervical spondylosis | |
| CN106177311A (en) | For treating the medicine of lumbago and skelalgia | |
| CN106109760A (en) | For treating the medicine of prolapse of lumbar intervertebral disc | |
| CN105079302A (en) | Medicine for treating wind-cold-dampness arthralgia and meridian and collateral obstruction type cervical spondylosis | |
| CN105106861A (en) | Medicine for treating traumatic type cervical spondylosis | |
| CN104352737A (en) | Traditional Chinese medicinal preparation for treating rheumatic low back and leg pain | |
| CN103961657A (en) | External traditional Chinese medicinal powder used for treating trauma | |
| CN106138778A (en) | For treating the medicine of trauma type cervical spondylosis | |
| CN104940316A (en) | Externally applied liniment used for treating protrusion of lumbar intervertebral disc | |
| CN107519454A (en) | It is a kind of to be used to treat decoction medicine of cervical spondylopathy and preparation method thereof | |
| CN105079258A (en) | Medicine for treating liver and kidney deficiency and qi and blood deficiency type cervical spondylosis | |
| CN106924379A (en) | A kind of decoction medicine for treating lumbar vertebrae hyperosteogeny and preparation method thereof | |
| CN105012592A (en) | Drug for treatment of chronic lumbar disc herniation | |
| CN106215113A (en) | For treating the medicine of damp-heat type dysmenorrhea | |
| CN104686710A (en) | Formula and production method of tendon and bone strengthening tea containing common curculigo rhizome | |
| CN105168681A (en) | Medicine for treating lumbar disc herniation with syndrome of blood stasis and preparation method of medicine | |
| CN103566117A (en) | Ointment for external use for bone-injury hemorrhagic disease and preparation method thereof | |
| CN103877335A (en) | Medicine for curing rheumatoid arthritis and preparation method of medicine | |
| CN104958477A (en) | Medicine for treating acute lumbar disc herniation | |
| CN118267360A (en) | Tougu Zhuifeng hot compress health care powder and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161116 |
|
| WD01 | Invention patent application deemed withdrawn after publication |